Every lot is tried & tested in a relevant biological assay.
Our Bioassay
- Middleton, R.E. et al. (2002) Biochemistry 41, 14734.
- Hall, E.O. et al. (2010) FASEB J. 24, 608.14.
- Alomone Labs ProTx-II blocks human NaV1.5 current stably expressed in HEK-293 cells.hNaV1.5 currents were elicited by 50 ms voltage ramp from the holding potential of -100 mV to +60 mV, applied every 10 sec using whole-cell voltage clamp technique. Left: Superimposed traces of hNaV1.5 currents measured under control conditions and after 100 sec perfusion with 50, 100 and 200 nM ProTx-II (#STP-100), as indicated. Inset: Time course of hNaV1.5 current amplitude change as a result of 10, 25, 50, 100 and 200 nM ProTx-II application, as indicated by the horizontal bars. Right: ProTx-II dose response of hNaV1.5 currents (n = 3).
- Middleton, R.E. et al. (2002) Biochemistry 41, 14734.
- Smith, J.J. et al. (2005) J. Biol. Chem. 280, 11127.
- Smith, J.J. et al. (2007) J. Biol. Chem. 282, 12687.
ProTx-II is a peptidyl toxin originally produced in Thrixopelma pruriens, the Peruvian green velvet tarantula. It was identified as a voltage-gated Na+ channel (NaV) blocker which inhibits both tetrodotoxin-sensitive and tetrodotoxin-resistant channels1.
Binding of ProTx-II to an extracellular domain of NaV channel, probably to a hydrophobic site3, inhibits current by shifting the channel activation to more positive potentials1-2.
ProTx-II Inhibits NaV1.2, NaV1.3, NaV1.5, NaV1.6, NaV1.7, and NaV1.8. It is a significantly more potent inhibitor against NaV1.7 than the other NaV channel subtypes1.
ProTx-II was also found as an effective modulator which shifts the voltage dependence activity of T-type Ca2+ channel1.
Alomone Labs ProTx-I and ProTx-II inhibit T-type CaV channels.ProTx-I (#STP-400) was applied to mouse thalamic neurons and ProTx-II (#STP-100) was tested on mouse DRGs. ProTx-I blocks native mouse CaV3.1 channel and recombinant human CaV3.1 channel currents similarly, and blocks to a lesser extent CaV3.2 and CaV3.3 channel currents. ProTx-II blocks CaV3.2 channels more potently than the other T-type currents.Adapted from Bladen, C. et al. (2014) Mol. Brain 7, 36. with permission of BioMed Central.
ProTx-II (#STP-100) is a highly pure, synthetic, and biologically active peptide toxin.
Applications
Citations
- Salari, A. et al. (2016) Sci. Rep. 6, 1.
- Bladen, C. et al. (2014) Mol. Brain 7, 36.
Specifications
Scientific Background
Related Products
- ProTx-II-Biotin (#STP-100-B)
- Anti-NaV1.5 (SCN5A) (1978-2016) Antibody (#ASC-013)
- Anti-NaV1.7 (SCN9A) Antibody (#ASC-008)
- Anti-CaV3.2 (CACNA1H) Antibody (#ACC-025)
- ProTx-I (#STP-400)
- ProTx-III (#STP-150)
- Pterinotoxin-2 (#STT-150)
- Pterinotoxin-1 (#STT-100)
- VSTX3 (#STT-350)
- Amlodipine besylate (#A-120)
- PF-05241328 (#P-345)
- µ-Conotoxin KIIIA (#C-280)
- NaV1.7-Compound 36 (#CMN-003)
- PF-05186462 (#P-365)
- NaV Channel Blockers for Pain Research Explorer Kit (#EK-375)
- TTX-Sensitive NaV Channel Blocker Explorer Kit (#EK-105)
- TTX-Resistant NaV Channel Blocker Explorer Kit (#EK-106)
- T-Type CaV Channel Blocker Explorer Kit (#EK-111)
Resources
Need Help With This Product?
Our reagent specialists are here to help you find the best product for your application. Please call or email us and we will be happy to help you find the right product for the job.
Call us at
+972 2587 2202 or Email Us